Your browser doesn't support javascript.
loading
A Canadian Commentary on the NKF-ASN Task Force Recommendations on Reassessing the Inclusion of Race in Diagnosing Kidney Disease.
Auguste, Bourne L; Nadeau-Fredette, Annie Claire; Parekh, Rulan S; Poyah, Penelope S; Perl, Jeffrey; Sood, Manish M; Tangri, Navdeep.
Afiliação
  • Auguste BL; Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Nadeau-Fredette AC; Division of Nephrology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Parekh RS; Hôpital Maisonneuve-Rosemont Research Center, Department of Medicine, Université de Montréal, Montréal, QC, Canada.
  • Poyah PS; Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Perl J; Women's College Hospital, Toronto, ON, Canada.
  • Sood MM; Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada.
  • Tangri N; Nova Scotia Health Authority, Central Zone, Halifax, NS, Canada.
Kidney Med ; 6(1): 100746, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38143561
ABSTRACT
In 2021, a committee was commissioned by the Canadian Society of Nephrology to comment on the 2021 National Kidney Foundation-American Society of Nephrology Task Force recommendations on the use of race in glomerular filtration rate estimating equations. The committee met on numerous occasions and agreed on several recommendations. However, the committee did not achieve unanimity, with a minority group disagreeing with the scope of the commentary. As a result, this report presents the viewpoint of the majority members. We endorsed many of the recommendations from the National Kidney Foundation-American Society of Nephrology Task Force, most importantly that race should be removed from the estimated glomerular filtration rate creatinine-based equation. We recommend an immediate implementation of the new Chronic Kidney Disease Epidemiology Collaboration equation (2021), which does not discriminate among any group while maintaining precision. Additionally, we recommend that Canadian laboratories and provincial kidney organizations advocate for increased testing and access to cystatin C because the combination of cystatin C and creatinine in revised equations leads to more precise estimates. Finally, we recommend that future research studies evaluating the implementation of the new equations and changes to screening, diagnosis, and management across provincial health programs be prioritized in Canada.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Kidney Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Kidney Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá
...